STOCK OPTION AGREEMENT (Director)Stock Option Agreement • January 30th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT made and entered into as of ______, 20___, by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and _________, a director (the “Optionee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTNon-Qualified • January 30th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT made and entered into as of _______, 20XX, by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
AGEX THERAPEUTICS, INC. Restricted Stock Units Award AgreementRestricted Stock Units Award Agreement • January 30th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Units Award Agreement (the “Award Agreement”) memorializes the grant on ____________ (the “Grant Date”) by AGEX THERAPEUTICS, INC. (the “Company”) to _______________ (“Participant”) of the number of Restricted Stock Units (the “Units”) indicated below under the Company’s 2017 Equity Incentive Plan (the “Plan”), including rights to Dividend Equivalents thereon. Each Unit granted hereunder represents a right to receive one share of common stock, par value $0.0001 per share, of the Company (“Common Stock”).
RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • January 30th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (“Agreement”) made and entered into as of ___________, 2016 (the “Grant Date”), by and between AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), and _____________, an employee (the “Employee”) of the Company.
